Scopulariopsis brevicaulis as the cause of dermatomycosis.

Scopulariopsis (S.) brevicaulis (Saccardo) Bainier 1907 is a ubiquitous fungus frequently isolated as a saprophyte from various layers of the soil, wood, straw, paper, food, and occasionally in animals and humans. This nondermatophyte filamentous fungus is multiresistant and is frequently associated with onychomycosis in humans. In the last two decades, the number of reports on its pathogenic role in different localized and disseminated infections has been on an increase. Identification was done by native KOH microscopy and culture on the Mycobios selective agar (Biolife). From January 1, 2002 till January 23, 2008, a total of 7161 samples were examined by use of mycology methods; S. brevicaulis accounted for 39 (2.2%) of 1834 (25.6%) positive samples. During the study period, S. brevicaulis was isolated from nail, skin and scalp scrapings of 39 patients (17 male and 22 female), mean age ( SD) 43.920.7 (range 8-87) years. Specimens were most frequently obtained from the foot (n=16; 41%), i.e. great toe nail in 10 and other foot areas in 6 cases, followed by palm and fingers in 8 (20.5%), scalp in 3 (7.7%) and other parts of the body in 12 (30.8%) cases. Most of the study subjects lived in a rural setting (n=22; 56%), working as farmers in close contact with the soil and domestic animals. Seventeen (44%) subjects were from urban setting (n=9) or unknown place of residence (n=8). Underlying risk factors were present in 29 (74%) of 39 study subjects, some of them with multiple risk factors. Besides close contact with the soil, the most common predisposing factors were various dermatoses (atopic dermatitis, psoriasis, dysseborrhea, etc.), lower extremity circulatory insufficiency, trauma, microtrauma, and metabolic disorders. Although the clinical picture of onychomycosis caused by S. brevicaulis shows some specific features, timely sampling for mycology is crucial to verify the diagnosis and to identify the causative agent prior to the introduction of appropriate therapy for dermatomycosis.

[1]  J. Guarro,et al.  In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis. , 2007, International journal of antimicrobial agents.

[2]  A. Bonifaz,et al.  Onychomycosis by molds. Report of 78 cases. , 2007, European journal of dermatology : EJD.

[3]  M. Schluchter,et al.  Specific Molds Associated With Asthma in Water-Damaged Homes , 2006, Journal of occupational and environmental medicine.

[4]  M. J. Buitrago,et al.  In Vitro Activities of 10 Combinations of Antifungal Agents against the Multiresistant Pathogen Scopulariopsis brevicaulis , 2006, Antimicrobial Agents and Chemotherapy.

[5]  I. Takiuchi,et al.  Scopulariopsis brevicaulis による爪真菌症の1例 , 2006 .

[6]  R. Summerbell,et al.  Forty-Eight-Hour Diagnosis of Onychomycosis with Subtyping of Trichophyton rubrum Strains , 2006, Journal of Clinical Microbiology.

[7]  M. J. Buitrago,et al.  Head-to-Head Comparison of the Activities of Currently Available Antifungal Agents against 3,378 Spanish Clinical Isolates of Yeasts and Filamentous Fungi , 2006, Antimicrobial Agents and Chemotherapy.

[8]  I. Takiuchi,et al.  [A case of onychomycosis induced by Scopulariopsis brevicaulis]. , 2006, Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology.

[9]  A. Agoumi,et al.  Les onychomycoses au Maroc , 2005 .

[10]  C. Romano,et al.  Onychomycosis in children: a survey of 46 cases , 2005, Mycoses.

[11]  W. Kern,et al.  Breakthrough Invasive Infection Due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a Stem Cell Transplant Patient Receiving Liposomal Amphotericin B and Caspofungin for Suspected Aspergillosis , 2005, Infection.

[12]  G. Quindós,et al.  Actividad antifúngica in vitro de voriconazol contra dermatofitos y aislamientos superficiales de Scopulariopsis brevicaulis , 2005 .

[13]  C. Romano,et al.  Retrospective study of onychomycosis in Italy: 1985–2000 , 2005, Mycoses.

[14]  Maria José Figueras,et al.  Atlas of clinical fungi. , 2005 .

[15]  A. Agoumi,et al.  [Onychomycosis in Morocco: experience of the parasitology and medical mycology laboratory from Rabat children hospital (1982-2003)]. , 2005, Annales de biologie clinique.

[16]  G. Quindós,et al.  [In vitro antifungal activity of voriconazole against dermatophytes and superficial isolates of Scopulariopsis brevicaulis]. , 2005, Revista iberoamericana de micologia.

[17]  E. Svejgaard,et al.  Onychomycosis in Denmark: prevalence of fungal nail infection in general practice , 2004, Mycoses.

[18]  M. A. Malecha.  Fungal Keratitis Caused by Scopulariopsis brevicaulis Treated Successfully With Natamycin , 2004, Cornea.

[19]  S. Goettmann-Bonvallot.  Variétés cliniques des onychomycoses , 2003 .

[20]  K. Ng,et al.  Scopulariopsis brevicaulis infection in a patient with acute myeloid leukemia. , 2003, The Medical journal of Malaysia.

[21]  L. Misery,et al.  Mycose sous-cutanée à Scopulariopsis brevicaulis chez un malade en aplasie , 2003 .

[22]  B. Piraccini,et al.  Treatment of nondermatophyte mold and Candida onychomycosis. , 2003, Dermatologic clinics.

[23]  M. J. Buitrago,et al.  Scopulariopsis brevicaulis, a Fungal Pathogen Resistant to Broad-Spectrum Antifungal Agents , 2003, Antimicrobial Agents and Chemotherapy.

[24]  L. Misery,et al.  [Subcutaneous mycosis due to Scopulariopsis brevicaulis in an aplasic patient]. , 2003, Annales de dermatologie et de vénéréologie.

[25]  S. Goettmann-Bonvallot.  [Clinical types of onychomycosis]. , 2003, Annales de dermatologie et de vénéréologie.

[26]  Jasna Lipozenčić,et al.  ACTA DERMATOVENEROLOGICA CROATICA , 2003 .

[27]  D. Larone.  Medically important fungi , 1994 .

[28]  Diagnostik pathogener Pilze des Menschen und seiner Umwelt , 1982 .